News and Articles on Ayurveda, Yoga, Kundalini and other Indian way of health and medicines.
The Indian Council for Medical Research (ICMR) has fast-tracked the roll-out of the global ‘Solidarity’ trial launched by the World Health Organization (WHO) towards finding an effective treatment for COVID-19.
Trikonasana strengthens the legs, knees, ankles, arms, and chest. It helps improve digestion and reduces anxiety, stress, as well as back pain.
“The COVID-19 test bus is based on indigenous technology and is the first vehicle of its kind in the world with onboard genetic testing, artificial intelligence (AI)-based teleradiology and contactless sample collection. We chose Mumbai as the launch location given the relatively high number of cases in the city,” says Ravi Sharma, president of IIT Alumni Council, in a release.
Union minister of state for AYUSH Shripad Y Naik on Thursday said that the AYUSH Ministry and the Council of Scientific and Industrial Research (CSIR) will begin clinical trials of four Ayurvedic formulations on COVID-19 patients within a week.
Jubilant Generics Ltd, a subsidiary of Jubilant Life Sciences Ltd, has entered into a non-exclusive licencing agreement with US-based Gilead Sciences Inc to manufacture and sell the potential COVID-19 drug remdesivir in 127 countries, including India.
Benefits of Virabhadrasana 1 are that it stretches the stomach, chest, shoulders, and neck. It strengthens arms and back muscles, along with thighs, calves, and ankles.
CSIR’s constituent lab, Institute of Genomics and Integrative Biology (CSIR-IGIB) and TATA Sons signed a MoU for licensing of KNOWHOW for FNCAS9 Editor Linked Uniform Detection Assay (FELUDA) for rapid diagnosis of COVID-19.
Amid lockdown many Pradhan Mantri Bharatiya Janaushadhi Kendras(PMBJK) under the Union Ministry of Chemicals and Fertilizers are accepting the orders for medicines on WhatsApp and e-mail, where on the basis of uploaded prescriptions medicines are delivered at the doorsteps of the patients.
An ayurvedic drug in India called ZingiVir-H has gotten the rubber stamp to conduct clinical trials on adults who have tested positive for coronavirus in India.
Technologists at the Sree Chitra Triunal Institute for Medical Sciences and Technology (SCTIMST), an autonomous institute under the Department of Science and Technology, Govt of India, have developed two types of nasal and oral swabs and viral transport medium for COVID-19 testing.
